Anti-Tumor Efficacy of Photodynamic Therapy of Solid Tumors in Laboratory Animals with Guanidine and Biguanidine Derivatives of Chlorine e6

Bull Exp Biol Med. 2023 Feb;174(4):468-472. doi: 10.1007/s10517-023-05731-3. Epub 2023 Mar 13.

Abstract

We evaluated antitumor efficacy of photodynamic therapy of murine Ehrlich carcinoma and rat sarcoma M-1 with new photosensitizers 131-N-(4-aminobutyl)amydo chlorine e6 (1), 132-(5-guanidylbutanamido)-chlorine e6 (2), and 132-(5-biguanidylbutanamido)-chlorine e6 (3). The inhibiting effect of the photodynamic therapy was evaluated by the following parameters: tumor growth inhibition, complete regression of the tumors, and absolute growth rate of the tumor nodes in animals with the continued neoplasia growth. The criterion of cure was the absence of tumors up to 90 days after the therapy. It is shown that the studied photosensitizers have high antitumor activity in the photodynamic therapy of the Ehrlich carcinoma and sarcoma M-1.

Keywords: Ehrlich carcinoma; photodynamic therapy; photosensitizers; sarcoma M-1; tumor regression.

MeSH terms

  • Animals
  • Animals, Laboratory
  • Carcinoma* / drug therapy
  • Guanidine
  • Guanidines
  • Mice
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Porphyrins* / pharmacology

Substances

  • Photosensitizing Agents
  • phytochlorin
  • Guanidine
  • Guanidines
  • Porphyrins